ArriVent BioPharma (AVBP) Stock Chart & Stock Price History → 4 Cryptos BETTER than Bitcoin (From True Market Insiders) (Ad) Free AVBP Stock Alerts $18.97 -0.27 (-1.40%) (As of 05/28/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends ArriVent BioPharma Stock Price Performance5 Day Performance+0.48%1 Month Performance+22.86%3 Month Performance-7.24% Receive AVBP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stansberry ResearchA once-in-a-century investment opportunityIt's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more potential than the AI stocks most investors are focused on in the days ahead.To get its name and ticker symbol for free - just click here. AVBP Stock Chart for Wednesday, May, 29, 2024 AVBP Chart by TradingView ArriVent BioPharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/28/2024$19.24$18.97-1.40%$19.66$18.7045,529 shs$635.31 million05/27/2024$19.24$19.24$19.24$18.1281,000 shs$644.35 million05/24/2024$18.88$19.24+1.91%$19.24$18.1281,061 shs$644.35 million05/23/2024$19.89$18.88-5.08%$20.13$18.7521,554 shs$632.29 million05/22/2024$19.95$19.89-0.30%$21.00$19.8159,222 shs$666.20 million05/21/2024$19.58$19.95+1.89%$20.34$19.6941,194 shs$668.13 million Get the Latest News and Ratings for AVBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter. 05/20/2024$20.10$19.58-2.59%$20.40$19.2940,311 shs$655.73 million05/17/2024$20.15$20.10-0.25%$20.85$19.9965,380 shs$673.15 million05/16/2024$19.50$20.15+3.33%$20.74$19.3056,995 shs$674.82 million05/15/2024$18.46$19.50+5.63%$19.55$18.7451,360 shs$653.06 million05/14/2024$17.93$18.46+2.96%$18.80$17.6839,373 shs$618.23 million05/13/2024$17.70$17.93+1.30%$18.51$16.9747,943 shs$600.48 million05/10/2024$17.99$17.70-1.61%$18.00$17.3927,905 shs$592.84 million05/09/2024$17.36$17.99+3.63%$17.99$17.3630,615 shs$602.56 million05/08/2024$17.25$17.36+0.64%$17.85$16.8240,811 shs$581.46 million05/07/2024$17.24$17.25+0.06%$17.62$17.0241,505 shs$577.77 million05/06/2024$17.23$17.24+0.06%$17.63$16.9325,226 shs$577.37 million05/03/2024$16.80$17.23+2.56%$17.51$16.7623,943 shs$577.03 million05/02/2024$16.69$16.80+0.66%$17.39$16.5462,370 shs$562.70 million05/01/2024$16.52$16.69+1.03%$17.42$15.7965,808 shs$558.95 million04/30/2024$16.34$16.52+1.10%$16.96$15.66108,462 shs$553.26 million04/29/2024$15.44$16.34+5.83%$16.64$15.3652,617 shs$547.23 million04/26/2024$15.54$15.44-0.64%$16.47$15.4053,529 shs$517.09 million04/25/2024$15.30$15.54+1.57%$15.88$14.3568,890 shs$520.44 million04/24/2024$15.77$15.30-2.98%$16.08$14.75130,345 shs$512.40 million04/23/2024$15.90$15.77-0.82%$16.29$15.3186,950 shs$528.20 million04/22/2024$15.50$15.90+2.58%$16.65$15.60115,535 shs$532.49 million04/19/2024$15.50$15.50$16.26$15.1734,155 shs$519.10 million04/18/2024$16.04$15.50-3.37%$17.04$14.74629,988 shs$519.10 million04/17/2024$16.80$16.04-4.52%$16.93$15.50194,788 shs$537.18 million04/16/2024$17.00$16.80-1.18%$17.55$16.44258,462 shs$562.63 million04/15/2024$16.89$17.00+0.65%$17.35$16.55311,965 shs$569.33 million04/12/2024$17.67$16.89-4.41%$17.85$16.6797,650 shs$565.65 million04/11/2024$17.29$17.67+2.20%$17.95$17.1071,831 shs$591.77 million04/10/2024$17.33$17.29-0.23%$17.66$16.9196,319 shs$579.04 million04/09/2024$17.49$17.33-0.91%$17.83$17.15132,269 shs$580.45 million04/08/2024$18.45$17.49-5.20%$18.54$17.34137,708 shs$585.74 million04/05/2024$18.30$18.45+0.82%$18.98$18.1241,494 shs$617.89 million04/04/2024$18.12$18.30+0.99%$18.54$17.8577,510 shs$612.94 million04/03/2024$18.00$18.12+0.67%$18.20$17.87122,190 shs$606.84 millionNext President (Not Trump. Not Biden.) (Ad)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.Click here to see why it will be ______ _________.04/02/2024$18.31$18.00-1.69%$18.20$17.92138,099 shs$575.28 million04/01/2024$17.86$18.31+2.52%$19.11$17.74357,779 shs$585.19 million03/29/2024$17.86$17.86$18.30$17.73233,160 shs$570.75 million03/28/2024$18.00$17.86-0.78%$18.30$17.73233,160 shs$570.81 million03/27/2024$17.80$18.00+1.12%$18.31$17.50121,847 shs$575.28 million03/26/2024$16.96$17.80+4.95%$18.04$16.91132,790 shs$568.89 million03/25/2024$18.28$16.96-7.22%$18.22$16.90121,475 shs$542.04 million03/22/2024$18.21$18.28+0.38%$18.46$17.8484,716 shs$584.23 million03/21/2024$18.42$18.21-1.14%$18.51$17.58172,738 shs$581.99 million03/20/2024$18.13$18.42+1.60%$18.67$17.67178,129 shs$588.70 million03/19/2024$18.55$18.13-2.26%$18.57$17.65298,818 shs$579.38 million03/18/2024$19.49$18.55-4.82%$19.78$18.14301,289 shs$592.86 million03/15/2024$18.57$19.49+4.95%$20.15$18.281.97 million shs$622.90 million03/14/2024$19.75$18.57-5.97%$19.75$17.69261,998 shs$593.50 million03/13/2024$19.15$19.75+3.13%$19.83$19.02149,831 shs$631.21 million03/12/2024$19.33$19.15-0.93%$19.96$18.75159,785 shs$612.03 million03/11/2024$19.61$19.33-1.43%$20.32$19.10111,746 shs$617.79 million03/08/2024$20.10$19.61-2.44%$20.70$19.6191,477 shs$626.74 million03/07/2024$20.25$20.10-0.74%$20.72$19.65121,599 shs$642.40 million03/06/2024$20.43$20.25-0.88%$21.43$20.11107,710 shs$647.19 million03/05/2024$22.75$20.43-10.20%$22.50$20.43139,563 shs$652.88 million03/04/2024$20.94$22.75+8.64%$22.99$20.57183,082 shs$727.09 million03/01/2024$21.54$20.94-2.79%$22.20$20.60136,934 shs$669.24 million02/29/2024$20.45$21.54+5.33%$22.29$20.34169,140 shs$688.42 million02/28/2024$19.54$20.45+4.66%$21.01$19.12306,712 shs$653.58 million02/27/2024$18.94$19.54+3.17%$20.10$18.61229,685 shs$624.50 million Related Companies: Dianthus Therapeutics Stock Chart Harrow Stock Chart Arbutus Biopharma Stock Chart Calliditas Therapeutics AB (publ) Stock Chart Zymeworks Stock Chart Pharming Group Stock Chart Mineralys Therapeutics Stock Chart Phathom Pharmaceuticals Stock Chart ORIC Pharmaceuticals Stock Chart Nuvation Bio Stock Chart Receive AVBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVBP) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersWrite this ticker symbol down…StocksToTradeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss RatingsBiden replacement revealed?Paradigm PressTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ArriVent BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.